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Conclusion: There is a clear-cut increment in life threatening ventricular tachyarrhyth- 
mia incidence in ICD patients in weeks after 9/l 1 with a return to baseline after approxi- 
mately 30 days. 
(n=50, 19% of total), a cause of SCD remained uncertain in only 36% (~~0.05 vs VW). 
CAD accounted for 13 cases. No patient (YW or VU) received an implantable defibrilla- 
tor. 
Conclusions: In women age 20-34 years, there was an unexpectedly high rate of unex- 
plained SCD compared to man (56% vs 36%; peO.05). A prospective, population-based 
evaluation of SCD in this age group is warranted. 
1016-11 Antecedent Hypertension Predisposes to Arrhythmic 
Death After Acute Myocardial Infarction: An Insight 
From Contemporary Survival Studies 
Yee Guan Yap, Trinh Duong. Martin Bland, Christian Tarp-Pederson, Lars Kober, Marek 
Malik, Stuart Connolly, Bradley Marchant, A. John Camm, St. George’s Hospital Medical 
School, London, United Kingdom 
Background: Arrhythmic death (AD) is the commonest mode of death after acute myo- 
cardial infarction (AMI) but the role of antecedent hypertension (AH) on the risk of 
arrhythmic death after AMI is unknown. Methods: We pooled the individual data on 3105 
placebo patient (247lM, median age: 65 (23-92)) from E.M.I.A.T.. C.A.M.I.A.T., 
S.W.O.R.D., T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. with LVEF<40% or frequent ventricular 
ectopics. Survival was measured from day 45 after Ml to allow for different recruitment 
periods. Cox multiple regression was used. Results: There were 466 deaths by 2 years 
(220 AD & 172 non-arrhythmic cardiac death (NAD)). After adjusted for significant vari- 
ables associated with either AD or NAD (age, previous MI. gender, angina, systolic blood 
pressure, heart rate, NYHA class, LVEF & Q-wave). patients with AH had a significantly 
higher ratio of AD to NAD at 2 years after the index infarct, but not in patients without AH. 
Cause-specific P-year incidence (AD:NAD, %): AH= 11 .O : 6.4: no AH= 7.7 : 7.2. Ratio of 
relative hazard of AD:NAD (95% Cl): AH= 1.65 (1.02-2.65); no AH=l, p= 0.04. The inter- 
action between AH and AD versus NAD is even greater when measuring from the time of 
index infarct in T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. patients only (p= 0.006). Conclu- 
sion: Our study provides the first data that AH predisposes to AD at 24 months after 
AMI. Such data is vital in refining the risk stratification of high risk patients similar to those 
of MADIT II patients for expensive implantable defibrillator therapy 
1016-12 Sex Selection in Unexplained Sudden Cardiac Death 
Kivon Chunq, Benjamin John, Vivek Dogra. Zhi-Jie Zheng, JackTitus, Sumeet S. Chugh. 
Oregon Health & Science University, Portland, OR, Jesse E. Edwards Registry of 
Cardiovascular Disease, St. Paul. MN 
Background: The US Centers for Disease Control and Prevention recently reported a dis- 
proporiionate increase in sudden cardiac death (SCD) in the youngest US women YS 
man (32% vs 10%; age group 15-34 y) during 1969-1996. 
Methods: Due to under-representation of this age group in existing autopsy series, we 
explored the etiologies of SCD in US women (VW) and men (YM) age 20-34 yrs from a 
13-year (1964.1996) autopsy series of SCD. All consecutive cases of SCD referred to 
the JE Edwards Registry from a US 3-county area ware analyzed. Autopsy reports were 
examined, archived hearts subjected to detailed gross/histologic examination and corra- 
lation made with clinical history, toxicologic screen 8 circumstances of death. 
Results: Of 270 total cases (age X20 yrs), YW constituted 14% (n=39). A definitive cause 
of SCD could not be determined in 22 (56%). Findings in other patients included myo- 
carditis (n=4), arrhythmogenic right ventricular dysplasia (n=3), congenital heart disease 
(n=2). coronary artery disease (CAD, n=2), and coronary artery anomalies (n=2). In YM 
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1017-l Prevention of Atrial Fibrillation by Atrial Overdrive 
Pacing: Final Results of a Randomized Crossover Study 
Karl-Heinz Kon~ Johannes Brachmann, Patrick Attuel, Dia El Allaf. Candid0 Games. 
lstvan Szendey, Volker Schibgilla, Dejan Danilovic, Maria Hilf Clinics, 
Moenchengladbach, Germany, Coburg Clinics, &burg, Germany 
Background: Dynamic atrial overdrive at a rate slightly above the intrinsic rate may sup- 
press recurrences of atrial tachyarrhythmia (AT) in pacemaker patients (pts). We evalu- 
ated clinical efficacy of the DDD+ overdrive mode in dual chamber Inos2 CLS 
pacemakers (Biotronik, Germany). 
Methods: 100 pts with paroxysmal AT and conventional pacing indications (71% sinus 
node disease, 25% atrioventricular block) were randomized to DDD+ or DDD mode at 3 
months after pacemaker implantation. A bipolar atrial lead was placed in the right 
appendage (60%) or laterally (40%). The basic rate was programmed to 61.5 r 4.3 
beatslmin (bpm). Upon sensing an atrial event, the DDD+ mode increased the pacing 
rate by 6 + 2 bpm. followed by 1 bpm rate decrease after each 20 * 3 atrial beats. The 
modes were crossed 6 months after randomization, and the pts were followed for 6 
months in the other mode. The cumulative duration of sustained (> 60 s) AT episodes 
was extracted from the pacemaker memory and compared for the two modes on intrapa- 
tient basis (paired two-tailed t-test). The comparison was made for the entire study popu- 
lation and for different subgroups of pts, in order to evaluate clinical predictors of the 
overdrive therapy outcome. 
Results: Crossover data ware collected in 75 pts; the remaining 25 pts were drop-outs. 
The AT burden was reduced by 26%, from 16.3 (DDD) to 12.0 hours/week (DDD+, p = 
0.066). In 32 pts with AT burden >2% of time (30 miniday), the reduction was 26%, from 
37.6 (DDD) to 27.0 h/week (DDD+, p = 0.044). The subgroups of pts with the most signif- 
icant reduction in AT burden were: 50 pts with < 60% of atrial pacing in DDD mode: 16.1 
(DDD) vs 6.6 h/week (DDD+, 45% reduction, p = 0.016), 25 pts with the basic rate sat to 
65-75 bpm: 29.0 (DDD) vs 16.6 h/week (DDD+, 43% reduction, p = O.Oll), and 34 pts 
who did not take beta-blocker drugs: 16.0 (DDD) vs 7.1 h/week (DDD+, 55% reduction, p 
= 0.026). In the complementary groups to these 3 subgroups there was no additional 
benefit of DDD+ over DDD pacing (O-l 1% reduction in AT burden, p > 0.57). 
Conclusion: DDD+ overdrive pacing exerted the strongest antiarrhythmic effect in pts 
paced less than 60% of time in the DDD mode, in pts with basic rate set to 65-75 bpm, 
and in pts taking no beta-blocker drugs. 
1017-2 Impact of Prevention Pacing Algorithms on Atrlal 
Tachyarrhythmia Recurrence Patterns in Patients 
Suffering From Brady-Tachy Form of Sick Sinus 
Syndrome: A Randomized Study 
Renato Ricci, Luiai Padeletti Gian Luca B&o, Giuseppe Boriani. Stefano Favale, 
Andrea Spampinato, Alessandro Capucci, Michele Gulizia. Paolo Rizzon, Pa& 
Pieragnoli, Marco Vimercati. Andrea Grammatico. Massimo Santini. San Filippo Neri 
Hospital, Rome, Italy 
Background. Preventive atrial pacing may reduce the incidence of atrial fibrillation (AF). 
either by eliminating the triggers and/or by modifying the substrate of the arrhythmia, but 
convincing results about prevention pacing impact from randomized and controlled stud- 
ies are still missing. 
Aim. A prospective, randomized multicentric study has been designed to measure prs- 
vention algorithms impact on AF burden, AF frequency and new endpoints, based on the 
number of sinus rhythm (SR) and AF days, in patients suffering from the brady-tachy 
foml of sick sinus syndrome. 
Methods.108 patients (age 72.3e2.7 years; 52.6% male) from 15 centers wars implanted 
with a DDDRP pacing system (Model AT500, Medtronic, Inc.) including three prevention 
pacing algorithms (Prev). Patients were randomized one-month post implant to DDDR or 
DDDR+Prev for 3 months and then crossed over for additional 3 months. 
Results, by using pacemaker diagnostics, were as follows: 
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flow (PVF). Hemodynamics were compared during DO0 pacing (90 bpm) from each site 
at AV delays of 90, 120, 150 and 180 ins following AV nodal ablation. Results: CO, dP/dt 
and LVEDP did not change wth site or delay. EDD varied significantly (pqO.05) with AV 
delay at all lead locations. MAP depended on AV delay during RAA and DSRA, but not 
BB and CSO pacing. Minimum PVF following atrial contraction, an index of PV transport. 
depended significantly on both AV delay and atrlal lead location (table). Conclusions: BB 
pacing maintained PV transpori during atrial contraction relative to RAA and DSRA pac- 
ing in anesthetized dogs with normal tntra-atrial conduction. Other hemodynamic parsm- 
eters were unchanged. PV flow patterns may influence mechanical triggers of AF. 
Endpoint 
AF frequency 
(episodes per day) 
AF burden 
(minutes per day) 
SR interval length 
(days) 
Percentage of days with 
AF 
DDDR DDDR+Prev p value 
Average*st.dev. Average*st.dev. 
(median) (median) 
[coefficient of variation] [coefficient of variation] 
0.90 * 2.56 (0.04) 0.92 * 2.40 (0.01) 0.96 
[286 %] [261 %] 
180.2 + 369.1 (3.4) 154.4 * 319.7 (5.3) 0.43 
[205 %] [207 %I 
10*18(2) 15 * 27 (2) 0.20 
[I80 %] [182 %] 
5.7 + 8.7 (0.9) 3.7 * 6.6 (0.4) 0.02 
[153 %] [178%] 
I W 
1 Frequencies of time intervals between the onset of consecutive atrial arrhythmia detec- 
tions were fined by power law functions showing that DDDR+Prev pacing is associated 
to longer SR intervals (slope 1.15) when compared to DDDR pacing (slope 1.25). Con- 
clusions. Prevention pacing significantly decreased the percentage of days with symp- 
tomatic or asymptomatic AF episodes and increased SR intervals. AF frequency and AF 
burden high variability may limit the capability to measure prevention patina impact via 
standard &as”res dr central tendenc;. 
_. 
1017-3 Three-Dimensional Noncontact Mapping Demonstrates 
Synergistic Electrophysiologic Effects of Multisite Atrial 
Pacing and Linear Atrial Ablation in Patients With 
Refractory Atrial Fibrillation 
Artur Filipecki, Sanieev Saksena, Atul Prakash, George Philip, Atlantic Health System, 
Passaic, NJ 
Background: While linear right atrial (RA) ablation has limited efficacy in atrial fibrillation 
(AF) & dual site RA pacing (DAP) can be efficacious, the electrophysiologic effects of 
combined “hybrid’ therapy have not been studied using 3-D non-contact mapping 
(NCM). Methods: We examined global atrial activation & RA activation before 8 after RA 
maze in pts with refractory AF & evaluated the impact of DAP after RA maze using NCM. 
Results: 30 pts, mean age 69clO yrs, mean LA size 42+9 mm, mean LVEF 43+/-12%. 
with cardiac disease (n=25) were studied. Mean P wave duration (Figure) increased after 
maze from 139_+19 to 169+20 (pc.001) & mean P wave amplitude was reduced from 1.9 
to 1 .l mV(pc.05). NCM showed linear intra-atrial block & segmentation into anterior & 
posterior RA comparlments. Slow & prolonged RA actwation was noted in both compati- 
ments after maze. Spontaneous macro-reentrant tachycardias around linear lesions or in 
a compartment after maze were seen in 8 pts (26%) P wave duration was reduced by 
DAP to 13&16(pc.O01). DAP produced 2 simultaneous RA wavefronts, one in each RA 
compartment resynchronizing them & preventing spontaneous tachycardias. Global atrial 
activation time was reduced by 10.30% (mean 18%). Conclusions: 1. RA maze proce- 
dures produce conduction delay, prolong global atrial activation & can promote mac- 
roreentrant arrhythmias. 2. DAP resynchronizes RA maze compartments & prevents 
macroreentry 3. DAP & RA maze have potential for synergy in antiarrhythmic effects in 
hybrid therapy of AF 
1017-4 Bachmann s Bundle Region Pacing Maintains 
Pulmonary Venous Transport Compared to Right Atrial 
Appendage and Dual Site Right Atrial Pacing 
Douglas A. Henrick. Paul D. Ziegler, Jacquelyn P. Kulinski. Rahul Mehra. Medtronic, Inc., 
Minneapolis, MN 
Background: Alternate atrial pacing lead locations including Bachmann’s Bundle 
region(BB), the coronary sinus ostium &SO), and dual site pacing from the right atrial 
appendage (RAA) and CSO (DSRA) have been proposed for prevention of atrial fibrilla- 
tion (AF). These pacing sites may also affect AF indirectly by changing atrial contraction 
patterns and hence atrial and pulmonary venous transport function. We compared hemo- 
dynamic indices during dual chamber pacing from the RAA, BB, CSO and DSRA. Meth- 
ods: Ansesthetized dogs (n=7, 27+2 kg) were instrumented for measurement of left atrial 
(LA), left ventricular end diastolic (LVEDP), and mean arterial pressure (MAP), dP/dt, LA 
volume, LV end-diastolic diameter (EDD), cardiac output (CO) and pulmonary venous 
Minimum PVF (mllmin) 
AV Delay (ms) 90 120 150 160 
RAA 2*11 5& 24*6 54*1 Fbd 
BB 18*11 24ztlO 36+12 73*]1 @C 
cso 7*14 11*9 27+10 64+lgbc 
DSRA 8*12 6+136 24*8 69*1 3abc 
a PCO.05 vs. 90ms b p-zo.05 vs. 120, c p<o.o5 vs. 150, d p<0.05 vs BB 
1017-s Combined Atrial Pacing Prevention Algorithms Reduce 
Atrial Tachyarrhythmia Burden in Bradycardia Patients 
With Frequent Premature Atrial Contractions and 
Standard Atrial Lead Placement: ASPECT Trial Results 
Mark Hawsv, Reece Holbrook. Martin Young, Brent Sakowski. Andrew Mugglm, Doug 
Henrick, The Worldwide ASPECT Investiaators. Presbvlerian Hospital. Oklahoma Citv. 
OK, Medtronic, Minneapolis, MN - 
Background: Atrial prevention pacing algorithms (PPA) have previously been shown to 
reduce the frequency of premature atrial contractions (PAC) in bradycardia patients with 
a history of atrial tachyarrhythmias (AT). Whether this reduction is associated with a 
reducticn in AT burden in patients with high PAC frequency is unknown. 
Methods: 120 patients with a Class 1 pacing indication and a history of paroxysmal AT 
receiving a DDDRP pacemaker with AT and PAC detection and enhanced far-field R- 
wave rejection features (AT500, Medtronic) including 69 patients with atrial septal leads 
were eligible for analysis. After a one-month monitoring period with DDDR pacing at 60 
ppm, patients were randomized to 3 months of PPA programmed ON or OFF in a cross- 
over fashion. Patients were stratified into two groups based on whether their PAC fre- 
quency during the monitoring period was above or below the median PAC frequency in 
the overall group (2841iday). Device classified AT burden was compared between PPA 
ON and OFF periods. 
Results: High PAC frequency during the monitoring period was associated with burden 
reduction during the PPA ON period in patients with non-septal, but not with sepia1 lead 
placement (Table). In the 60 patients with PAC frequency < 284l/day, no significant dif- 
ference in burden between the PPA ON and OFF periods was observed, regardless of 
lead placement. 
Patients with PAC 
Frequency>284l/day 
ALL 
Non-Sepia1 
Septa1 
n Median Burden Reduction (on-off) p 
(hr/day) 
6 -0.04 0.0 
0 8 
2 -0.63 0.0 
9 4 
3 0.01 0.4 
1 2 
Conclusion: Patients with non-septal lead placement and high frequency PAC’s may rsp- 
resent a responder group for atrial prevention pacing algonthms. 
1017-6 Effects of Atrial Septal Lead Location on Atrial 
Tachyarrhythmia Detection and Device Diagnostics in 
Bradycardia Patients 
H. Piirerfellner, Reece Holbrook, Martin Young, Jaquelyn Kulinski, Jodi Koehler, Doug 
Henrick. A.6. Krankenhaus der Elisabethinen Linz, Linz, Austria, Medtronic, Minneapolis, 
MN 
Background: The Impact of atrial septal lead placement on the accuracy of atrial tach- 
yarrhythmia (AT) detection is unknown. 
Methods: Patients with a history of bradycardia and AT were randomized to atrial sepia1 
or non-septal lead placement and implanted with a DDDRP pacemaker (AT500, 
Medtronic). Each stored episode was classified for appropriateness of AT detection (i.e. 
AT confirmed at episode onset) and termination (i.e. sinus or paced rhythm confirmed at 
device-classified episode termination). Positive predictive value (PPV) was adjusted for 
multiple episodes within a patient.’ AT episodes from septal patients were analyzed by 
lead position (low, mid, or high-septal). 
Results: A total of 16,843 stored episodes were analyzed from 239 patients. PPV for epi- 
sode detection was similar for both lead locatIons (Table). The PPV of episode termlna- 
tion was significantly lower for patients with septal leads. Most inappropriately terminated 
episodes were followed by appropriate w-detection within 1 minute. The PPV value of 
